Recommend Cell Cycle to your librarian for 2008. Download form here.

Sign up for Table of Contents Alerts.

home subscribe search archive forthcoming

Email this page Print this page

Report

Mice lacking both mixed-lineage kinase genes Mlk1 and Mlk2 retain a wild type phenotype

Nicolas Bisson, Michel Tremblay, Fiona Robinson, David R. Kaplan, Steven P. Trusko and Thomas Moss

volume 7 | issue 7

1 April 2008
Pages: 909 - 916

This is an open-access article

 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.

The mitogen-activated protein kinase kinase kinases of the mixed-lineage kinase (MLK) family have been shown to activate the c-Jun N-terminal kinase (JNK) mitogen-activated protein kinase (MAPK) pathway, and to regulate the other two principal MAPK cascades, p38 and extracellular signal-regulated kinase (ERK). Although there is growing evidence for their involvement in neuronal cell death leading to neurodegenerative disorders, little in vivo data is available for the members of this family of kinases. Here, we report that the inactivation of mouse Mlk1 and Mlk2 genes. Mlk1-/- and Mlk2-/- mice were found to be viable and healthy. Surprisingly, mice carrying the compound Mlk1/Mlk2 null mutations were also found to be viable, fertile and to have a normal life span. The nervous system, testis and kidney, the major sites of MLK1 and 2 expression, all appear normal, as do other organs where these kinases were found to be more weakly expressed. Surprisingly, developmental neuronal programmed cell death, another potential target for MLK family members, was also found to be unaffected. Our results suggest that there is extensive functional redundancy between MLK1/MLK2 and the other member of the family, MLK3, which is also not required for survival in mouse.

Authors

Nicolas Bisson

Laval University; Quebec, Canada

Michel Tremblay

Laval University; Quebec, Canada

Fiona Robinson

Hospital for Sick Children; Toronto, Ontario, Canada

David R. Kaplan

Hospital for Sick Children; Toronto, Ontario, Canada

Steven P. Trusko

Cephalon, Inc.; West Chester, PA

Thomas Moss

Cancer Research Centre, CHUQ-HDQ, Pav. St Patrick


This is an open-access article

 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.